This IMAX CEO Sale Closes Out a Decade-Old Options Grant

IMAX (NYSE:IMAX), a leader in immersive cinema technology, reported a recent insider sale amid ongoing global expansion and strong price gains. Richard L. Gelfond, Chief Executive Officer of IMAX, reported the open-market sale of 8,943 common shares for a transaction value of approximately $334,000 on April 27, 2026, as disclosed in a SEC Form 4…


This IMAX CEO Sale Closes Out a Decade-Old Options Grant

IMAX (NYSE:IMAX), a leader in immersive cinema technology, reported a recent insider sale amid ongoing global expansion and strong price gains.

Richard L. Gelfond, Chief Executive Officer of IMAX, reported the open-market sale of 8,943 common shares for a transaction value of approximately $334,000 on April 27, 2026, as disclosed in a SEC Form 4 filing.

Transaction summary

Metric

Value

Shares sold (direct)

8,943

Transaction value

~$334,000

Post-transaction shares (direct)

765,002

Post-transaction value (direct ownership)

~$56.8 million

Transaction value based on SEC Form 4 weighted average purchase price ($37.33); post-transaction value based on April 27, 2026 market close ($37.12).

Key questions

  • What does the 8,943-share sale represent in the context of Gelfond’s overall stake?
    This transaction accounted for only 1.17% of Gelfond’s direct holdings, indicating a minimal reduction relative to his remaining 1,530,004 common shares and does not materially alter his exposure to IMAX.

  • Was the sale part of a routine liquidity program or a discretionary sale?
    The sale was executed under a pre-scheduled Rule 10b5-1 trading plan and involved the exercise and immediate sale of stock options, consistent with routine portfolio management rather than discretionary selling.

  • How does this trade compare to Gelfond’s recent activity in terms of size and cadence?
    The 8,943-share sale is the smallest among seven sell transactions since May 2025, with prior trades ranging from 25,024 to 135,046 shares, a pattern explained by Gelfond’s progressively lower remaining share capacity after substantial prior dispositions.

  • What ongoing equity exposure does Gelfond retain after this transaction?
    Gelfond directly holds 765,002 common shares following the transaction.

Company overview

Metric

Value

Revenue (TTM)

$404.92 million

Net income (TTM)

$43.46 million

Employees

700

1-year price change

46.86%

* 1-year price change calculated as of May 1, 2026.

Company snapshot

  • Offers proprietary IMAX Digital Re-Mastering (DMR) technology, large-format projection systems, post-production services, and maintenance for a global network of IMAX theaters.

  • Generates revenue through system sales, leases, joint revenue sharing arrangements, maintenance services, and content distribution to both commercial and institutional clients.

  • Serves multiplex operators, museums, aquaria, educational centers, and entertainment venues in 87 countries and territories.

IMAX is a global leader in entertainment technology, specializing in immersive cinematic experiences through its proprietary projection and sound systems. The company leverages its extensive intellectual property and global theater network to deliver premium large-format content and services to both commercial and institutional customers. IMAX’s competitive advantage lies in its advanced DMR technology and established brand presence across a diversified international footprint.

Source link